文献速递心脏核医学核素与放射性配体治疗

心脏交感神经活性与机械性不同步作为心脏再同步化治疗反应预测因素的价值:缺血性与非缺血性心力衰竭患者的比较

The value of cardiac sympathetic activity and mechanical dyssynchrony as cardiac resynchronization therapy response predictors: comparison between patients with ischemic and non-ischemic heart failure.
PubMed 文献 · J Nucl Cardiol · 2022-07-14

本研究纳入58例接受心脏再同步化治疗(CRT)的心力衰竭患者,在CRT前进行123I-MIBG显像和CZT门控心肌灌注显像(MPI),随访一年。非缺血性心衰患者中,123I-MIBG延迟心脏/纵隔摄取比是CRT反应的独立预测因素(OR 1.469;95%CI 1.076-2.007,p=.003);缺血性心衰患者中,CZT门控MPI获得的机械性不同步指数直方图带宽(HBW)对CRT反应有预测价值(OR 1.06,95%CI 1.001-1.112,p=.005)。

要点

  • 非缺血性心衰患者中,123I-MIBG延迟心脏/纵隔摄取比是CRT反应的独立预测因素(OR 1.469)。
  • 缺血性心衰患者中,CZT门控MPI的机械性不同步指数HBW对CRT反应有预测价值(OR 1.06)。
  • 123I-MIBG显像和CZT门控MPI可能有助于预测CRT反应,改善候选患者的结局。

核心结论

  • CRT反应可通过心脏123I-MIBG显像预测,非缺血性心衰中依据心脏/纵隔摄取比,缺血性心衰中依据机械性不同步指数HBW。
  • 这些结果提示一种可能有用的算法来改善接受CRT候选心衰患者的结局。

研究设计与样本

  • 研究纳入58例转诊接受CRT的心力衰竭患者。
  • CRT前所有患者均接受123I-MIBG显像和使用镉锌碲(CZT)SPECT/CT设备的门控心肌灌注显像(MPI)。
  • CRT后一年随访评估CRT反应。

主要发现

  • 非缺血性心衰患者中,123I-MIBG延迟心脏/纵隔摄取比是CRT反应的独立预测因素(OR 1.469;95%CI 1.076-2.007,p=.003)。
  • 缺血性心衰患者中,CZT门控MPI获得的机械性不同步指数直方图带宽(HBW)对CRT反应有预测价值(OR 1.06,95%CI 1.001-1.112,p=.005)。

关键数值与推荐

  • 非缺血性心衰:123I-MIBG延迟心脏/纵隔摄取比预测CRT反应,OR 1.469(95%CI 1.076-2.007,p=.003)。
  • 缺血性心衰:CZT门控MPI的机械性不同步指数HBW预测CRT反应,OR 1.06(95%CI 1.001-1.112,p=.005)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Impaired cardiac sympathetic activity and mechanical dyssynchrony (MD) are associated with poor prognosis in patients with heart failure (HF) after cardiac resynchronization therapy (CRT). The study aims to assess the significance of scintigraphic evaluation of cardiac sympathetic innervation and contractility in predicting response to CRT in patients with ischemic and non-ischemic chronic HF. METHODS AND RESULTS: The study includes 58 HF patients, who were referred for CRT. Prior to CRT all patients underwent 123I-metaiodobenzylguanidine (123I-MIBG) imaging and gated myocardial perfusion imaging (MPI) using a cadmium-zinc-telluride (CZT) SPECT/CT device. At a one-year follow-up post-CRT, the delayed heart-to-mediastinum 123I-MIBG uptake ratio was an independent predictor of CRT response in non-ischemic HF patients (OR 1.469; 95% CI 1.076-2.007, p = .003). In ischemic HF patients the MD index histogram bandwidth (HBW) obtained by CZT-gated MPI had a predictive value (OR 1.06, 95% CI 1.001-1.112, p = .005) to CRT response. CONCLUSION: CRT response can be predicted by cardiac 123I-MIBG scintigraphy, specifically by the heart-to-mediastinum ratio in non-ischemic HF and by the MD index HBW in ischemic HF. These results suggest the value of a potentially useful algorithm to improve outcomes in HF patients who are candidates for CRT.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Mishkina AI, Saushkin VV, Atabekov TA, et al. The value of cardiac sympathetic activity and mechanical dyssynchrony as cardiac resynchronization therapy response predictors: comparison between patients with ischemic and non-ischemic heart failure. J Nucl Cardiol. 2022. PMID: 35834158. doi:10.1007/s12350-022-03046-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。